Fennec Pharmaceuticals (FENC) gains 9.6% stakeholder via Rosalind Advisors

Rhea-AI Filing Summary

Fennec Pharmaceuticals Inc. received an updated ownership report from Rosalind Advisors Inc. and related parties. They report beneficial ownership of up to 3,321,333 common shares, representing 9.6% of Fennec’s common stock, based on 34,737,030 shares outstanding as of May 12, 2026.

Rosalind Master Fund L.P. holds 3,188,001 shares with shared voting and dispositive power, while Steven Salamon and Gilad Aharon each have sole voting and dispositive power over 66,666 shares plus shared power over 3,188,001 shares. Rosalind Advisors and Mr. Salamon may be deemed beneficial owners but both disclaim beneficial ownership.

Key Figures

Rosalind Advisors beneficial ownership: 3,321,333 shares (9.6%) Rosalind Master Fund holdings: 3,188,001 shares (9.2%) Shares outstanding: 34,737,030 shares +2 more

5 metrics

Rosalind Advisors beneficial ownership 3,321,333 shares (9.6%) Common shares of Fennec Pharmaceuticals beneficially owned by Rosalind Advisors Inc.

Rosalind Master Fund holdings 3,188,001 shares (9.2%) Common shares of Fennec Pharmaceuticals held with shared voting and dispositive power

Shares outstanding 34,737,030 shares Fennec common shares outstanding as of May 12, 2026 used to calculate percentages

Individual sole holdings 66,666 shares each Sole voting and dispositive power for both Steven Salamon and Gilad Aharon

Shared voting block 3,188,001 shares Shares over which Rosalind Advisors, Rosalind Master Fund, Salamon and Aharon share voting and dispositive power

Key Terms

beneficial owner, shared voting power, dispositive power, percent of class, +1 more

5 terms

beneficial owner financial

"may be deemed to be the beneficial owner of shares held by RMF"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

shared voting power financial

"Shared Voting Power 3,321,333.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

dispositive power financial

"Sole Dispositive Power 66,666.00 8 | Shared Dispositive Power 3,188,001.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class financial

"The percentage set forth in Row 11 of the cover page for each Reporting Person"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Schedule 13G regulatory

"The information as of the date of the event which requires filing of this statement"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What ownership stake in Fennec (FENC) does Rosalind Advisors report?

Rosalind Advisors Inc. reports a 9.6% beneficial ownership in Fennec Pharmaceuticals, tied to 3,321,333 common shares. This percentage is calculated against 34,737,030 shares outstanding of Fennec’s common stock as of May 12, 2026.

How many Fennec (FENC) shares does Rosalind Master Fund L.P. hold?

Rosalind Master Fund L.P. reports holding 3,188,001 Fennec common shares with shared voting and dispositive power. This position represents 9.2% of the outstanding common stock based on 34,737,030 shares outstanding as of May 12, 2026.

What is the reported ownership percentage of Steven Salamon in FENC?

Steven Salamon reports beneficial ownership of 9.4% of Fennec’s common shares, or 3,254,667 shares. This includes 66,666 shares over which he has sole voting and dispositive power and 3,188,001 shares subject to shared power.

What is the reported ownership percentage of Gilad Aharon in FENC?

Gilad Aharon reports beneficial ownership of 9.4% of Fennec’s common shares. He has sole voting and dispositive power over 66,666 shares and shared voting and dispositive power over 3,188,001 shares held through the Rosalind structure.

On what share count is the Fennec (FENC) ownership percentage based?

The reported ownership percentages are based on 34,737,030 Fennec common shares outstanding as of May 12, 2026. That figure comes from Fennec’s Form 10-Q filed on May 14, 2026, which the reporting persons reference.

Do Rosalind Advisors and Steven Salamon admit full beneficial ownership of FENC shares?

Rosalind Advisors Inc. and Steven Salamon state they may be deemed beneficial owners of shares held by Rosalind Master Fund L.P. However, both expressly disclaim beneficial ownership of those shares in the filing language.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 10:31 AM Accepted by SEC EDGAR 08/13/2026 - 10:31 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

FENNEC PHARMACEUTICALS INC.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

31447P100

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 31447P100

1

Names of Reporting Persons

Rosalind Advisors, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,321,333.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,321,333.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,321,333.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.6 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP Number(s): 31447P100

1

Names of Reporting Persons

SALAMON STEVEN A J

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 66,666.00
6	Shared Voting Power 3,188,001.00
7	Sole Dispositive Power 66,666.00
8	Shared Dispositive Power 3,188,001.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,254,667.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP Number(s): 31447P100

1

Names of Reporting Persons

Aharon Gil

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 66,666.00
6	Shared Voting Power 3,188,001.00
7	Sole Dispositive Power 66,666.00
8	Shared Dispositive Power 3,188,001.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,188,001.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP Number(s): 31447P100

1

Names of Reporting Persons

Rosalind Master Fund L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,188,001.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,188,001.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,188,001.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.2 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: FENNEC PHARMACEUTICALS INC.
(b)	Address of issuer's principal executive offices: PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NORTH CAROLINA, 27709.
Item 2.
(a)	Name of person filing: Rosalind Advisors Inc. Advisor to RMF Rosalind Master Fund L.P. RMF Steven Salamon President Steven Salamon is the portfolio manager of the Advisor which advises RMF. Gilad Aharon is the portfolio manager and member of the Advisor which advises RMF.
(b)	Address or principal business office or, if none, residence: Rosalind Advisors, Inc. 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada Rosalind Master Fund L.P. P.O. Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands Steven Salamon 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada Gilad Aharon 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada
(c)	Citizenship: Mr. Salamon and Mr. Aharon are citizens of Canada, resident in Ontario
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: 31447P100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information as of the date of the event which requires filing of this statement required by Items 4a to c is set forth in Rows 7 to 13 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 34,737,030 ordinary shares of the Issuers common stock outstanding as of May 12, 2026, based on the 10Q Filing of May14, 2026. Rosalind Advisors Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
(b)	Percent of class: Rosalind Advisors Inc. 9.6% Rosalind Master Fund L.P. 9.2% Steven Salamon 9.4% Gilad Aharon 9.4%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Steven Salamon - 66,666 Gilad Aharon - 66,666
	(ii) Shared power to vote or to direct the vote: Rosalind Advisors Inc. - 3,188,001 Rosalind Master Fund L.P. - 3,188,001 Steven Salamon - 3,188,001 Gilad Aharon - 3,188,001
	(iii) Sole power to dispose or to direct the disposition of: Steven Salamon - 66,666 Gilad Aharon - 66,666
	(iv) Shared power to dispose or to direct the disposition of: Rosalind Advisors Inc. - 3,188,001 Rosalind Master Fund L.P. - 3,188,001 Steven Salamon - 3,188,001 Gilad Aharon - 3,188,001
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rosalind Advisors, Inc.

Signature:	Steven Salamon
Name/Title:	President
Date:	08/13/2026

SALAMON STEVEN A J

Signature:	Steven Salamon
Name/Title:	Steven Salamon
Date:	08/13/2026

Aharon Gil

Signature:	Gil Aharon
Name/Title:	Gil Aharon
Date:	08/13/2026

Rosalind Master Fund L.P.

Signature:	Mike McDonald
Name/Title:	Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:	08/13/2026